{"id":"NCT02480621","sponsor":"Jamaica Hospital Medical Center","briefTitle":"Liposomal Bupivacaine With Bupivacaine in Ankle Fracture Open Reduction Internal Fixation (ORIF)","officialTitle":"The Impact of Liposomal Bupivicaine on Post-Operative Pain in Orthopaedic Trauma Surgery: A Double-Blind Prospective Randomized Control Trial","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-12","primaryCompletion":"2016-06-30","completion":"2016-08-31","firstPosted":"2015-06-24","resultsPosted":"2017-10-20","lastUpdate":"2017-10-20"},"enrollment":84,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Ankle Fracture"],"interventions":[{"type":"DRUG","name":"Liposomal Bupivacaine with Bupivacaine","otherNames":["Exparel"]}],"arms":[{"label":"Control","type":"NO_INTERVENTION"},{"label":"Liposomal Bupivacaine with Bupivacaine","type":"EXPERIMENTAL"}],"summary":"This study is a randomized controlled trial assessing pain control in ankle fractures repaired with open reduction and internal fixation. Patients are consented and enrolled pre-operatively, and randomized to either control or liposomal bupivacaine with bupivacaine administered intra-operatively.","primaryOutcome":{"measure":"Pain Levels on a Visual Analog Scale ( VAS)","timeFrame":"Immediate post-operative period until 72 hours post-operatively","effectByArm":[{"arm":"Control","deltaMin":7.05,"sd":2.87},{"arm":"Liposomal Bupivacaine With Bupivacaine","deltaMin":4.03,"sd":3.5}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.10"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["23977664","25830260","25750943","25614060"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":39},"commonTop":[]}}